Invention Grant
- Patent Title: Binding molecules that bind human complement factor C2 and uses thereof
-
Application No.: US15903810Application Date: 2018-02-23
-
Publication No.: US10717785B2Publication Date: 2020-07-21
- Inventor: Cornelis Erik Hack , Cafer Yildiz , Louis Boon , Petrus Johannes Simons
- Applicant: BROTEIO PHARMA B.V.
- Applicant Address: NL Utrecht
- Assignee: BROTEIO PHARMA B.V.
- Current Assignee: BROTEIO PHARMA B.V.
- Current Assignee Address: NL Utrecht
- Agency: Lathrop GPM LLP
- Agent James H. Velema, Esq.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@53c7764e
- Main IPC: C12N15/00
- IPC: C12N15/00 ; C12N5/00 ; C07H21/04 ; C07K16/00 ; C07K16/40 ; C07K16/18
Abstract:
The invention relates to means and methods that relate to binding molecules that bind human complement factor C2. Specific binding molecules are described with specific C2 activity inhibiting properties. Such binding molecules are useful in the treatment of symptoms of various human diseases among which there is inflammatory disease, neuro-inflammatory disease or ischemia-reperfusion (I/R) injury disease.
Public/Granted literature
- US20180319895A1 BINDING MOLECULES THAT BIND HUMAN COMPLEMENT FACTOR C2 AND USES THEREOF Public/Granted day:2018-11-08
Information query
IPC分类:
